whether Lantus increases cancer risk

August 2009

Patients are asking whether Lantus increases cancer risk.

Recent European studies suggest a higher cancer risk in patients using Lantus (insulin glargine) ALONE compared to other insulins.

A Swedish study suggests one extra case of breast cancer for every 1000 women using Lantus alone for 1 year compared to other insulins.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: PA includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote